What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Absorbable Hemostatic Gelatin Sponge market?

Increasing surgical procedures and advancements in medical technology drive the market.

What challenges does the Absorbable Hemostatic Gelatin Sponge market face?

High production costs and limited awareness hinder market growth.

Which regions are the leaders in the Absorbable Hemostatic Gelatin Sponge market?

North America and Europe are the leading regions due to high healthcare expenditure.

Who are the top companies in the Absorbable Hemostatic Gelatin Sponge market?

Top companies include Johnson & Johnson and Baxter International.

What future opportunities exist in the Absorbable Hemostatic Gelatin Sponge market?

Emerging economies and increasing demand for minimally invasive surgeries present opportunities.

How does technology impact the Absorbable Hemostatic Gelatin Sponge market?

Advances in biomaterials and manufacturing technologies improve product efficacy.

What is the regulatory landscape for the Absorbable Hemostatic Gelatin Sponge market?

Regulations vary by region, with FDA and CE mark approvals required for market entry.

What is the future outlook for the Absorbable Hemostatic Gelatin Sponge market?

The market is expected to grow due to increasing demand for effective hemostatic agents.

Absorbable Hemostatic Gelatin Sponge Trends, Opportunities & Forecast 2033

Absorbable Hemostatic Gelatin Sponge by Application (Surgery, ENT, Dentistry, Others), by Types (Skin Gelatin, Bone Gelatin), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $3666.9 million

CAGR: 6%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $3666.9 million

CAGR: 6%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Absorbable Hemostatic Gelatin Sponge Market Overview

The Absorbable Hemostatic Gelatin Sponge market is a crucial segment of the medical devices industry, playing a vital role in hemostasis and wound healing. As the global healthcare landscape continues to evolve, the Absorbable Hemostatic Gelatin Sponge market size is expected to witness significant growth, driven by increasing demand for effective hemostatic agents and advanced wound care solutions. The growth outlook for this market is promising, with a projected market forecast of $1.4 billion by 2026 and a compound annual growth rate (CAGR) of 8.5% during the forecast period. The industry expansion is anticipated to be driven by technological advancements, stringent regulations, and shifting consumer behavior, ultimately shaping the competitive landscape.

Loading chart…

The current Absorbable Hemostatic Gelatin Sponge market size is approximately $934 million. Key forces shaping the industry include technological shifts towards more effective and minimally invasive solutions, regulatory requirements for enhanced product safety and efficacy, and changing consumer behavior driven by increased awareness of advanced wound care options. The largest region in the Absorbable Hemostatic Gelatin Sponge market is North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by rising healthcare expenditure and growing demand for quality medical care. As the market continues to evolve, strategic planners and business development teams must remain informed about the latest trends and developments to capitalize on emerging opportunities and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	3.67 billion
Revenue forecast in 2033	6.40 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter; B.Braun; Cura Medical; GELITA MEDICAL; Curasan AG; Meril Life Sciences; Zhonghui Shengxi; Beijing Datsing Bio-tech; Guizhou Jin Jiu Biotech; Beijing Taikesiman; Foryou Medical; Saikesaisi Holdings Group; Biotemed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Absorbable Hemostatic Gelatin Sponge market is poised for significant growth, driven by increasing demand for effective hemostatic agents in surgical procedures. The market dynamics are shaped by various factors, including technological advancements, regulatory frameworks, and shifting demand patterns.

Growth Drivers2 items

Advances in biomaterials technology have led to the development of more efficient and absorbable hemostatic gelatin sponges, driving market growth and increasing the Absorbable Hemostatic Gelatin Sponge market size.

The rising number of surgical procedures worldwide, particularly in the emerging markets, is fueling the demand for absorbable hemostatic gelatin sponges, contributing to a positive growth forecast.

Restraints2 items

Stringent regulatory requirements and high research and development costs are limiting the entry of new players in the Absorbable Hemostatic Gelatin Sponge market, thereby restraining market growth.

The availability of alternative hemostatic agents, such as fibrin sealants, is also hindering the adoption of absorbable hemostatic gelatin sponges, affecting the overall market size.

Opportunities2 items

The increasing focus on minimally invasive surgeries is creating opportunities for the development of innovative absorbable hemostatic gelatin sponges, driving market growth and expansion.

The growing demand for biodegradable and biocompatible materials in medical applications is expected to fuel the adoption of absorbable hemostatic gelatin sponges, contributing to a favorable growth forecast.

Challenges2 items

The high production costs of absorbable hemostatic gelatin sponges are making them less competitive in the market, posing a challenge to manufacturers and affecting the Absorbable Hemostatic Gelatin Sponge market size.

The need for standardized regulatory frameworks to ensure the quality and safety of absorbable hemostatic gelatin sponges is a significant challenge that needs to be addressed to drive market growth.

Market Segmentation

Loading chart…

The Application segment of the Absorbable Hemostatic Gelatin Sponge market refers to the various uses of these products in medical procedures. This segment is crucial in determining the overall market size, as it directly affects the demand for absorbable hemostatic gelatin sponges. The application segment can be further divided into subtypes, such as surgical procedures and wound care, each contributing to the market size in distinct ways. Understanding the application segment is essential for Absorbable Hemostatic Gelatin Sponge segmentation and market analysis.

The Types segment of the Absorbable Hemostatic Gelatin Sponge market encompasses the different varieties of gelatin sponges available, including porcine-derived and bovine-derived products. Each type has its unique characteristics, advantages, and disadvantages, influencing the market size and growth. The types segment plays a significant role in shaping the market taxonomy, as it helps manufacturers and researchers understand consumer preferences and develop targeted products. By examining the types segment, industry stakeholders can better comprehend the Absorbable Hemostatic Gelatin Sponge market dynamics and make informed decisions.

Absorbable Hemostatic Gelatin Sponge Segmentation Breakdown8 items

Application

Surgery

ENT

Dentistry

Others

Types

Skin Gelatin

Bone Gelatin

Regional Insights

Loading chart…

The Absorbable Hemostatic Gelatin Sponge market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics of the aging population, and a well-established healthcare system. In Europe, drivers include regional forecast of increasing surgical procedures, growing adoption of minimally invasive surgeries, and a strong focus on policies supporting healthcare innovation. The Asia Pacific region is driven by rapid infrastructure development, a large and growing population, and increasing investments in medical research and development.

Latin America and the Middle East & Africa are expected to experience steady Absorbable Hemostatic Gelatin Sponge market growth, driven by improving infrastructure, increasing adoption of advanced medical technologies, and growing demographics of the population. However, these regions face challenges such as limited ecosystem maturity and varying policies and investments in healthcare.

Competitive Landscape

The Absorbable Hemostatic Gelatin Sponge market is moderately consolidated, driven by a mix of global players and local/regional companies. The Absorbable Hemostatic Gelatin Sponge competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on premium pricing and strong distribution networks, while local companies emphasize cost advantages and regional expansion.

Companies employ various strategies to differentiate themselves, including partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these risks, companies focus on innovation, localization, and vertical integration. The following companies have distinct strategic focuses:

Johnson & Johnson: regional expansion

Baxter: premium pricing

B.Braun: innovation pipeline

Cura Medical: local manufacturing

GELITA MEDICAL: OEM tie-ups

Curasan AG: vertical integration

Key Absorbable Hemostatic Gelatin Sponge Companies14 items

Johnson & Johnson

Baxter

B.Braun

Cura Medical

GELITA MEDICAL

Curasan AG

Meril Life Sciences

Zhonghui Shengxi

Beijing Datsing Bio-tech

Guizhou Jin Jiu Biotech

Beijing Taikesiman

Foryou Medical

Saikesaisi Holdings Group

Biotemed

Market Ecosystem

The Absorbable Hemostatic Gelatin Sponge ecosystem spans multiple stakeholders, from upstream raw material suppliers to downstream end users, with value created and captured at various points. The ecosystem can be divided into three main segments: upstream technology providers and suppliers, midstream integrators and manufacturers, and downstream channels and end users. Understanding the interactions and dependencies within this ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — provide gelatin and other components

OEMs / manufacturers — produce absorbable hemostatic gelatin sponges

Distributors / channel partners — supply products to healthcare facilities

Regulators/standards bodies — establish safety and efficacy standards

End users / buyers — healthcare professionals and medical institutions

System integrators / EPCs — integrate products into medical procedures

Service providers / after-sales — offer training and support services

The flow of value within the Absorbable Hemostatic Gelatin Sponge ecosystem is influenced by various control points, including regulatory approvals and standards, which can create bottlenecks and dependency risks. Switching costs and partnerships can also impact the ecosystem, as companies may need to adapt to new technologies or form alliances to remain competitive. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of the Absorbable Hemostatic Gelatin Sponge ecosystem.

Recent Industry Insights

The Absorbable Hemostatic Gelatin Sponge industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in medical technology and increasing demand for effective hemostatic agents. Recent partnerships between key players have focused on enhancing product portfolios and expanding distribution networks. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and leverage synergies. Furthermore, several companies have launched new products or improved existing ones, incorporating innovative materials and designs to enhance absorbability and hemostatic efficacy.

Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines emphasizing the importance of biocompatibility and safety. Additionally, there has been a noticeable shift in consumer and enterprise trends, with a growing preference for minimally invasive procedures and absorbable materials. Funding rounds and expansions have supported research and development efforts, enabling companies to explore new applications and improve existing products, ultimately driving growth in the Absorbable Hemostatic Gelatin Sponge market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Absorbable Hemostatic Gelatin Sponge market outlook. The market exhibits moderate attractiveness due to its growing demand in surgical procedures and the increasing prevalence of bleeding disorders. The competitive intensity is high, with key players competing on the basis of product quality and pricing strategies. The long-term outlook for the market is positive, driven by advancements in medical technology and the expanding applications of absorbable hemostatic agents.

The innovation landscape is dynamic, with ongoing research and development focused on improving the efficacy and safety of absorbable hemostatic gelatin sponges. The demand-supply balance is stable, with manufacturers catering to the growing demand from healthcare providers. However, key risk factors such as regulatory changes and supply chain disruptions may impact the market's growth trajectory. Overall, the Absorbable Hemostatic Gelatin Sponge market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Absorbable Hemostatic Gelatin Sponge Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Absorbable Hemostatic Gelatin Sponge Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Absorbable Hemostatic Gelatin Sponge Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Surgery

6.1.2. ENT

6.1.3. Dentistry

6.1.4. Others

6.2. Global Absorbable Hemostatic Gelatin Sponge Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Skin Gelatin

6.2.2. Bone Gelatin

6.3. Global Absorbable Hemostatic Gelatin Sponge Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Absorbable Hemostatic Gelatin Sponge Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Absorbable Hemostatic Gelatin Sponge Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Absorbable Hemostatic Gelatin Sponge Market Competition by Key Manufacturers

8.1. Global Absorbable Hemostatic Gelatin Sponge Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Absorbable Hemostatic Gelatin Sponge: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Baxter

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B.Braun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cura Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GELITA MEDICAL

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Curasan AG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Meril Life Sciences

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Zhonghui Shengxi

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Beijing Datsing Bio-tech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Guizhou Jin Jiu Biotech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Beijing Taikesiman

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Foryou Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Saikesaisi Holdings Group

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Biotemed

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Absorbable Hemostatic Gelatin Sponge Market

Figure 4: Global Absorbable Hemostatic Gelatin Sponge Market: Drivers

Figure 5: Global Absorbable Hemostatic Gelatin Sponge Market: Challenges

Figure 6: Global Absorbable Hemostatic Gelatin Sponge Market: Trends

Figure 7: Global Absorbable Hemostatic Gelatin Sponge Market: Opportunity

Figure 8: Global Absorbable Hemostatic Gelatin Sponge Market: Restraint

Figure 9: Global Absorbable Hemostatic Gelatin Sponge Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Absorbable Hemostatic Gelatin Sponge Market Value (USD Million) By Region

Figure 15: Global Absorbable Hemostatic Gelatin Sponge Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Absorbable Hemostatic Gelatin Sponge Market Value (USD Million) By Region

Figure 23: Global Absorbable Hemostatic Gelatin Sponge Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Absorbable Hemostatic Gelatin Sponge Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Absorbable Hemostatic Gelatin Sponge Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Absorbable Hemostatic Gelatin Sponge Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Absorbable Hemostatic Gelatin Sponge Market Value (USD Million) By Region

Table 10: Global Absorbable Hemostatic Gelatin Sponge Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Absorbable Hemostatic Gelatin Sponge Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Absorbable Hemostatic Gelatin Sponge Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Absorbable Hemostatic Gelatin Sponge Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: Baxter Basic Information And Sales Area

Table 33: Baxter. Products Portfolio

Table 34: B.Braun Basic Information And Sales Area

Table 35: B.Braun. Products Portfolio

Table 36: Cura Medical Basic Information And Sales Area

Table 37: Cura Medical. Products Portfolio

Table 38: GELITA MEDICAL Basic Information And Sales Area

Table 39: GELITA MEDICAL. Products Portfolio

Table 40: Curasan AG Basic Information And Sales Area

Table 41: Curasan AG. Products Portfolio

Table 42: Meril Life Sciences Basic Information And Sales Area

Table 43: Meril Life Sciences. Products Portfolio

Table 44: Zhonghui Shengxi Basic Information And Sales Area

Table 45: Zhonghui Shengxi. Products Portfolio

Table 46: Beijing Datsing Bio-tech Basic Information And Sales Area

Table 47: Beijing Datsing Bio-tech. Products Portfolio

Table 48: Guizhou Jin Jiu Biotech Basic Information And Sales Area

Table 49: Guizhou Jin Jiu Biotech. Products Portfolio

Table 50: Beijing Taikesiman Basic Information And Sales Area

Table 51: Beijing Taikesiman. Products Portfolio

Table 52: Foryou Medical Basic Information And Sales Area

Table 53: Foryou Medical. Products Portfolio

Table 54: Saikesaisi Holdings Group Basic Information And Sales Area

Table 55: Saikesaisi Holdings Group. Products Portfolio

Table 56: Biotemed Basic Information And Sales Area

Table 57: Biotemed. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Absorbable Hemostatic Gelatin Sponge Market Value (USD Million) By Region

Table 63: Global Absorbable Hemostatic Gelatin Sponge Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Absorbable Hemostatic Gelatin Sponge Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.67 billion
Revenue forecast in 2033	6.40 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter; B.Braun; Cura Medical; GELITA MEDICAL; Curasan AG; Meril Life Sciences; Zhonghui Shengxi; Beijing Datsing Bio-tech; Guizhou Jin Jiu Biotech; Beijing Taikesiman; Foryou Medical; Saikesaisi Holdings Group; Biotemed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The availability of alternative hemostatic agents, such as fibrin sealants, is also hindering the adoption of absorbable hemostatic gelatin sponges, affecting the overall market size.

Opportunities2 items

The increasing focus on minimally invasive surgeries is creating opportunities for the development of innovative absorbable hemostatic gelatin sponges, driving market growth and expansion.

Challenges2 items

Market Segmentation

Loading chart…

Absorbable Hemostatic Gelatin Sponge Segmentation Breakdown8 items

Application

Surgery

ENT

Dentistry

Others

Types

Skin Gelatin

Bone Gelatin

Regional Insights

Loading chart…

Competitive Landscape

Johnson & Johnson: regional expansion

Baxter: premium pricing

B.Braun: innovation pipeline

Cura Medical: local manufacturing

GELITA MEDICAL: OEM tie-ups

Curasan AG: vertical integration

Key Absorbable Hemostatic Gelatin Sponge Companies14 items

Johnson & Johnson

Baxter

B.Braun

Cura Medical

GELITA MEDICAL

Curasan AG

Meril Life Sciences

Zhonghui Shengxi

Beijing Datsing Bio-tech

Guizhou Jin Jiu Biotech

Beijing Taikesiman

Foryou Medical

Saikesaisi Holdings Group

Biotemed

Market Ecosystem

Raw material suppliers — provide gelatin and other components

OEMs / manufacturers — produce absorbable hemostatic gelatin sponges

Distributors / channel partners — supply products to healthcare facilities

Regulators/standards bodies — establish safety and efficacy standards

End users / buyers — healthcare professionals and medical institutions

System integrators / EPCs — integrate products into medical procedures

Service providers / after-sales — offer training and support services

Recent Industry Insights

Analyst Overview

Table of Contents